Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Lung Cancer

Free Subscription Articles published in Ann Oncol Retrieve available abstracts of 66 articles: HTML format

Single Articles

April 2008
1. GIACCONE G , Zucali PA
   Src as a potential therapeutic target in non-small-cell lung cancer.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. PAPAXOINIS G , Fountzilas G, Rontogianni D, Dimopoulos MA, et al
   Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
   Ann Oncol. 2008;19:780-6.
   PubMed     Related articles    Abstract available
   
   
   
3. FULCINITI F , Losito S, Botti G, Di Mattia D, et al
   Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years.
   Ann Oncol. 2008;19:682-7.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. JACOT W , Colinet B, Bertrand D, Lacombe S, et al
   Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. MACHIELS JP , Bletard N, Pirenne P, Jacquet L, et al
   Acute cardiac failure after sunitinib.
   Ann Oncol. 2008;19:597-9.
   PubMed     Related articles   
   
   
   
6. POWLES T , Robinson D, Shamash J, Moller H, et al
   The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
   Ann Oncol. 2008;19:443-7.
   PubMed     Related articles    Abstract available
   
   
   
7. KU GY , Minsky BD, Rusch VW, Bains M, et al
   Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.
   Ann Oncol. 2008;19:533-7.
   PubMed     Related articles    Abstract available
   
   
   
8. AAPRO M , Abrahamsson PA, Body JJ, Coleman RE, et al
   Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.
   Ann Oncol. 2008;19:420-32.
   PubMed     Related articles    Abstract available
   
   
   February 2008
9. WEISS GJ , Bemis LT, Nakajima E, Sugita M, et al
   EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. CULLEN MH , Zatloukal P, Sorenson S, Novello S, et al
    A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. DI MAIO M , Bria E, Rossi A, Perrone F, et al
    Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?
    Ann Oncol. 2008;.
    PubMed     Related articles   
    
    
    December 2007
12. D'ADDARIO G , Rauch D, Stupp R, Pless M, et al
    Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. WITZEL ID , Muller V, Harps E, Janicke F, et al
    Trastuzumab in pregnancy associated with poor fetal outcome.
    Ann Oncol. 2007;.
    PubMed     Related articles   
    
    
    October 2007
14. LEE JM , Lee KB, Nam JH, Ryu SY, et al
    Prognostic factors in FIGO stage IB IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. ROSELL R , Robinet G, Szczesna A, Ramlau R, et al
    Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. KOSMIDIS PA , Kalofonos HP, Christodoulou C, Syrigos K, et al
    Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
17. RUANO-RAVINA A , Perez-Becerra R, Fraga M, Kelsey KT, et al
    Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. LEE D , Kim SW, Suh C, Lee JS, et al
    Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. KIM DW , Kim SY, Kim HK, Kim SW, et al
    Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. SCAGLIOTTI GV
    Potential role of multi-targeted tyrosine kinase inhibitors in non-small-cell lung cancer.
    Ann Oncol. 2007;18 Suppl 10:x32-41.
    PubMed     Related articles    Abstract available
    
    
    August 2007
21. PAUTIER P , Ribrag V, Duvillard P, Rey A, et al
    Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
22. TOSCHI L , Cappuzzo F, Janne PA
    Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
    Ann Oncol. 2007;18 Suppl 9:ix150-5.
    PubMed     Related articles   
    
    
    
23. FELIP E , Cedres S, Peralta S, Prat A, et al
    Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).
    Ann Oncol. 2007;18 Suppl 9:ix143-6.
    PubMed     Related articles   
    
    
    
24. BESSE B , Ropert S, Soria JC
    Targeted therapies in lung cancer.
    Ann Oncol. 2007;18 Suppl 9:ix135-42.
    PubMed     Related articles   
    
    
    
25. STAHEL RA
    Adenocarcinoma, a molecular perspective.
    Ann Oncol. 2007;18 Suppl 9:ix147-9.
    PubMed     Related articles   
    
    
    
26. LARKIN JM , Kaye SB
    Potential clinical applications of epothilones: a review of phase II studies.
    Ann Oncol. 2007;18 Suppl 5:v28-34.
    PubMed     Related articles    Abstract available
    
    
    
27. MEDIONI J , Cojocarasu O, Belcaceres JL, Halimi P, et al
    Complete cerebral response with sunitinib for metastatic renal cell carcinoma.
    Ann Oncol. 2007;18:1282-3.
    PubMed     Related articles   
    
    
    
28. VINEIS P , Veglia F, Garte S, Malaveille C, et al
    Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
    Ann Oncol. 2007;18:1230-42.
    PubMed     Related articles    Abstract available
    
    
    June 2007
29. YU I , Tse L, Leung C, Wong T, et al
    Lung cancer mortality among silicotic workers in Hong Kong--no evidence for a link.
    Ann Oncol. 2007;18:1056-1063.
    PubMed     Related articles    Abstract available
    
    
    
30. LAURIE S , Ding K, Whitehead M, Feld R, et al
    The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group.
    Ann Oncol. 2007;18:1051-5.
    PubMed     Related articles    Abstract available
    
    
    
31. ROSATI G , Bilancia D, Germano D, Dinota A, et al
    Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study.
    Ann Oncol. 2007;18 Suppl 6:vi128-32.
    PubMed     Related articles    Abstract available
    
    
    
32. DIRIX LY , Maes H, Sweldens C
    Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors.
    Ann Oncol. 2007;18:1121-2.
    PubMed     Related articles   
    
    
    
33. BOFFETTA P
    Epidemiology of peritoneal mesothelioma: a review.
    Ann Oncol. 2007;18:985-90.
    PubMed     Related articles    Abstract available
    
    
    May 2007
34. 
    Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
    Ann Oncol. 2007;18 Suppl 2:ii32-ii33.
    PubMed     Related articles       Free Full Text
    
    
    
35. 
    Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
    Ann Oncol. 2007;18 Suppl 2:ii30-ii31.
    PubMed     Related articles       Free Full Text
    
    
    
36. DAGNELIE PC , Pijls-Johannesma MC, Lambin P, Beijer S, et al
    Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy.
    Ann Oncol. 2007;18:940-4.
    PubMed     Related articles    Abstract available
    
    
    April 2007
37. SCULIER J , Lafitte J, Lecomte J, Alexopoulos C, et al
    A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. ALTINTAS S , Blockx N, Huizing MT, Van den Brande J, et al
    Small-cell carcinoma of the penile urethra: a case report and a short review of the literature.
    Ann Oncol. 2007;18:801-4.
    PubMed     Related articles   
    
    
    March 2007
39. TAILLADE L , Penault-Llorca F, Boulet T, Fouret P, et al
    Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. NOVELLO S , Bruzzi P, Barone C, Buosi R, et al
    Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. WEISS G , Rosell R, Fossella F, Perry M, et al
    The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
    Ann Oncol. 2007;18:453-60.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
42. VAN ZANDWIJK N , van de Vijver MJ
    Clairvoyance or reliable prediction of the future?
    Ann Oncol. 2007;18:407-8.
    PubMed     Related articles   
    
    
    
43. VIEILLOT S , Pouessel D, de Champfleur NM, Becht C, et al
    Reversible posterior leukoencephalopathy syndrome after carboplatin therapy.
    Ann Oncol. 2007;18:608-9.
    PubMed     Related articles   
    
    
    
44. LEVI F , Lucchini F, Negri E, La Vecchia C, et al
    Continuing declines in cancer mortality in the European Union.
    Ann Oncol. 2007;18:593-5.
    PubMed     Related articles    Abstract available
    
    
    February 2007
45. DE RUYSSCHER D , Dehing C, Bremer RH, Bentzen S, et al
    Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. HIRSCH F , Varella-Garcia M, Cappuzzo F, McCoy J, et al
    Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. MANDALA M , Moro C, Michetti G, Ferretti G, et al
    What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
    Ann Oncol. 2007;18:404.
    PubMed     Related articles   
    
    
    December 2006
48. YOON S , Schmassmann-Suhijar D, Zuber M, Konietzny P, et al
    Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.
    Ann Oncol. 2006;17:1851-2.
    PubMed     Related articles   
    
    
    November 2006
49. BIDOLI P , Zilembo N, Cortinovis D, Mariani L, et al
    Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
50. DZIADZIUSZKO R , Holm B, Skov BG, Osterlind K, et al
    Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
51. OHE Y , Ohashi Y, Kubota K, Tamura T, et al
    Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
52. SOUGLAKOS J , Kalykaki A, Vamvakas L, Androulakis N, et al
    Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
53. SEIFART U , Fink T, Schade-Brittinger C, Hans K, et al
    Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
54. COMELLA P , Filippelli G, De Cataldis G, Massidda B, et al
    Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperativ
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
55. ROCHA-LIMA CM , Herndon JE 2nd, Lee ME, Atkins JN, et al
    Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
56. GALEONE C , Negri E, Pelucchi C, La Vecchia C, et al
    Dietary intake of fruit and vegetable and lung cancer risk: a case-control study in Harbin, northeast China.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
57. FISCHER BM , Mortensen J, Langer SW, Loft A, et al
    A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. VAN ZANDWIJK N , Mathy A, Boerrigter L, Ruijter H, et al
    EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
59. BELANI CP , Dakhil S, Waterhouse DM, Desch CE, et al
    Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. ANDRE T , Tournigand C, Mineur L, Fellague-Chebra R, et al
    Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
61. STAHEL RA
    Non-small cell lung cancer: second-line and beyond.
    Ann Oncol. 2006;17 Suppl 10:x97-x100.
    PubMed     Related articles   
    
    
    
62. FELIP E , Vilar E
    The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy.
    Ann Oncol. 2006;17 Suppl 10:x108-x112.
    PubMed     Related articles   
    
    
    
63. LORIOT Y , Soria JC, Le Chevalier T
    Expanding role of chemotherapy in lung cancer.
    Ann Oncol. 2006;17 Suppl 10:x101-x107.
    PubMed     Related articles   
    
    
    August 2006
64. ZELL JA , Ou SH, Ziogas A, Anton-Culver H, et al
    Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis.
    Ann Oncol. 2006;17:1255-62.
    PubMed     Related articles    Abstract available
    
    
    June 2006
65. ITALIANO A , Vandenbos FB, Otto J, Mouroux J, et al
    Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.
    Ann Oncol. 2006;17:981-5.
    PubMed     Related articles    Abstract available
    
    
    May 2006
66. CRIVELLARI D , Lombardi D, Corona G, Massacesi C, et al
    Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
    Ann Oncol. 2006;17:807-12.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: